| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8668519 | Journal of Clinical Lipidology | 2018 | 12 Pages |
Abstract
Pemafibrate was superior to fenofibrate in terms of serum TG-lowering effect and hepatic and renal safety.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shun MD, PhD, Hidenori MD, PhD, Koutaro MD, PhD, Eiichi MD, PhD, Hideki PhD, Shizuya MD, PhD, K-877 Study Group K-877 Study Group,